| MATR3 |
MATR3, KIAA0723: Matrin-3 |
SFRS14 |
SFRS14, KIAA0365: Putative splicing factor, arginine/serine-rich 14 |
0.307 |
Evidence |
|
| ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
0.307 |
Evidence |
|
| IGFBP3 |
IGFBP3, IBP3: Insulin-like growth factor-binding protein 3 precursor |
DAB2 |
DAB2, DOC2: Disabled homolog 2 |
0.307 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
SGSH |
SGSH, HSS: N-sulphoglucosamine sulphohydrolase precursor |
0.307 |
Evidence |
|
| ZNF24 |
ZNF24, KOX17, ZNF191, ZSCAN3: Zinc finger protein 24 |
SFRS14 |
SFRS14, KIAA0365: Putative splicing factor, arginine/serine-rich 14 |
0.307 |
Evidence |
|
| PNLIP |
PNLIP: Pancreatic triacylglycerol lipase precursor |
KRT20 |
KRT20: Keratin, type I cytoskeletal 20 |
0.307 |
Evidence |
|
| ANXA3 |
ANXA3, ANX3: Annexin A3 |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.307 |
Evidence |
|
| CD28 |
CD28: T-cell-specific surface glycoprotein CD28 precursor |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
0.307 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
0.307 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
SGSH |
SGSH, HSS: N-sulphoglucosamine sulphohydrolase precursor |
0.307 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
0.307 |
Evidence |
|
| CD7 |
CD7: T-cell antigen CD7 precursor |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
0.307 |
Evidence |
|
| CD7 |
CD7: T-cell antigen CD7 precursor |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
0.307 |
Evidence |
|
| IGFBP1 |
IGFBP1, IBP1: Insulin-like growth factor-binding protein 1 precursor |
DAB2 |
DAB2, DOC2: Disabled homolog 2 |
0.307 |
Evidence |
|
| SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
MGMT |
MGMT: Methylated-DNA--protein-cysteine methyltransferase |
0.307 |
Evidence |
|
| PLEK |
PLEK, P47: Pleckstrin |
GNAI2 |
Galphai2 protein |
0.307 |
Evidence |
|
| PLEK |
PLEK, P47: Pleckstrin |
ITGB7 |
ITGB7: Integrin beta-7 precursor |
0.307 |
Evidence |
|
| PLEK |
PLEK, P47: Pleckstrin |
GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
0.307 |
Evidence |
|
| PDHA1 |
PDHA1, PHE1A: Pyruvate dehydrogenase E1 component subunit alpha, somatic form, m |
TOP2A |
TOP2A, TOP2: DNA topoisomerase 2-alpha |
0.307 |
Evidence |
|
| HSP90AB1 |
HSP90AB1, HSP90B, HSPC2, HSPCB: Heat shock protein HSP 90-beta |
PDHA1 |
PDHA1, PHE1A: Pyruvate dehydrogenase E1 component subunit alpha, somatic form, m |
0.307 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
0.307 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
PLEK |
PLEK, P47: Pleckstrin |
0.307 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
0.307 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
SGSH |
SGSH, HSS: N-sulphoglucosamine sulphohydrolase precursor |
0.307 |
Evidence |
|
| PROC |
PROC: Vitamin K-dependent protein C precursor |
MGMT |
MGMT: Methylated-DNA--protein-cysteine methyltransferase |
0.307 |
Evidence |
|